Skip to search formSkip to main contentSkip to account menu

ATGAM

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Background:Immune-mediated myocarditis is an uncommon adverse effect of immune checkpoint inhibition and is associated with a… 
Highly Cited
2008
Highly Cited
2008
Background. Use of induction for renal transplantation is controversial because of the concerns about long-term safety and… 
Highly Cited
2006
Highly Cited
2006
Highly Cited
2006
Background. It is widely assumed that the graft-enhancing properties of antilymphocyte induction agents and their lymphoma… 
Review
2004
Review
2004
Background. One-year results of a randomized, double-blinded trial of Thymoglobulin versus Atgam for induction therapy in renal… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND The aim of this study was to compare the efficacy and safety of Thymoglobulin (a rabbit-derived polyclonal antibody… 
Highly Cited
1998
Highly Cited
1998
BACKGROUND Thymoglobulin, a rabbit anti-human thymocyte globulin, was compared with Atgam, a horse anti-human thymocyte globulin… 
Highly Cited
1995
Highly Cited
1995
Exposure to the equine-derived polyclonal antithymocyte preparation, ATGAM, frequently elicits human anti-ATGAM antibody… 
1995
1995
In August 1992, we replaced Minnesota antilymphocyte globulin (MALG) with lymphocyte immune globulin, antithymocyte globulin… 
Highly Cited
1985
Highly Cited
1985
Increasing evidence that Type 1 (insulin dependent) diabetes mellitus is an autoimmune disease, together with successful cure…